Serum albumin improves recovery from spinal cord injury

Lisa D. Cain, Linghui Nie, Michael G. Hughes, Kathia Johnson, Clement Echetebu, Guo Ying Xu, Claire E. Hulsebosch, David J. McAdoo

    Research output: Contribution to journalArticle

    12 Citations (Scopus)

    Abstract

    A neuroprotective factor is shown to be present in mammalian serum. This factor is identified by Western blotting to be serum albumin. The serum factor and albumin both protected cultured spinal cord neurons against the toxicity of glutamate. The inability of K252a, a blocker of the high affinity tyrosine kinase receptor for members of the nerve growth factor family, to block the neuroprotective effect of the serum factor established that the serum factor is not a member of the nerve growth factor family. Post-injury injection of albumin intravenously or into the site of injury immediately after injury both improved significantly locomotor function according to Basso-Beattie-Bresnahan assessment and spontaneous locomotor activity recorded with a photobeam activity system. Albumin has multiple mechanisms whereby it may be neuroprotective, and it is a potentially useful agent for treating neurotraumas.

    Original languageEnglish (US)
    Pages (from-to)1558-1567
    Number of pages10
    JournalJournal of Neuroscience Research
    Volume85
    Issue number7
    DOIs
    StatePublished - May 15 2007

    Fingerprint

    Spinal Cord Injuries
    Serum Albumin
    Nerve Growth Factor
    Albumins
    Wounds and Injuries
    Serum
    Receptor Protein-Tyrosine Kinases
    Neuroprotective Agents
    Locomotion
    Glutamic Acid
    Spinal Cord
    Western Blotting
    Neurons
    Injections

    Keywords

    • Albumin
    • Neuroprotection
    • Spinal cord injury

    ASJC Scopus subject areas

    • Neuroscience(all)

    Cite this

    Cain, L. D., Nie, L., Hughes, M. G., Johnson, K., Echetebu, C., Xu, G. Y., ... McAdoo, D. J. (2007). Serum albumin improves recovery from spinal cord injury. Journal of Neuroscience Research, 85(7), 1558-1567. https://doi.org/10.1002/jnr.21265

    Serum albumin improves recovery from spinal cord injury. / Cain, Lisa D.; Nie, Linghui; Hughes, Michael G.; Johnson, Kathia; Echetebu, Clement; Xu, Guo Ying; Hulsebosch, Claire E.; McAdoo, David J.

    In: Journal of Neuroscience Research, Vol. 85, No. 7, 15.05.2007, p. 1558-1567.

    Research output: Contribution to journalArticle

    Cain, LD, Nie, L, Hughes, MG, Johnson, K, Echetebu, C, Xu, GY, Hulsebosch, CE & McAdoo, DJ 2007, 'Serum albumin improves recovery from spinal cord injury', Journal of Neuroscience Research, vol. 85, no. 7, pp. 1558-1567. https://doi.org/10.1002/jnr.21265
    Cain LD, Nie L, Hughes MG, Johnson K, Echetebu C, Xu GY et al. Serum albumin improves recovery from spinal cord injury. Journal of Neuroscience Research. 2007 May 15;85(7):1558-1567. https://doi.org/10.1002/jnr.21265
    Cain, Lisa D. ; Nie, Linghui ; Hughes, Michael G. ; Johnson, Kathia ; Echetebu, Clement ; Xu, Guo Ying ; Hulsebosch, Claire E. ; McAdoo, David J. / Serum albumin improves recovery from spinal cord injury. In: Journal of Neuroscience Research. 2007 ; Vol. 85, No. 7. pp. 1558-1567.
    @article{8eff45768e094a879bd411d46754cf78,
    title = "Serum albumin improves recovery from spinal cord injury",
    abstract = "A neuroprotective factor is shown to be present in mammalian serum. This factor is identified by Western blotting to be serum albumin. The serum factor and albumin both protected cultured spinal cord neurons against the toxicity of glutamate. The inability of K252a, a blocker of the high affinity tyrosine kinase receptor for members of the nerve growth factor family, to block the neuroprotective effect of the serum factor established that the serum factor is not a member of the nerve growth factor family. Post-injury injection of albumin intravenously or into the site of injury immediately after injury both improved significantly locomotor function according to Basso-Beattie-Bresnahan assessment and spontaneous locomotor activity recorded with a photobeam activity system. Albumin has multiple mechanisms whereby it may be neuroprotective, and it is a potentially useful agent for treating neurotraumas.",
    keywords = "Albumin, Neuroprotection, Spinal cord injury",
    author = "Cain, {Lisa D.} and Linghui Nie and Hughes, {Michael G.} and Kathia Johnson and Clement Echetebu and Xu, {Guo Ying} and Hulsebosch, {Claire E.} and McAdoo, {David J.}",
    year = "2007",
    month = "5",
    day = "15",
    doi = "10.1002/jnr.21265",
    language = "English (US)",
    volume = "85",
    pages = "1558--1567",
    journal = "Journal of Neuroscience Research",
    issn = "0360-4012",
    publisher = "Wiley-Liss Inc.",
    number = "7",

    }

    TY - JOUR

    T1 - Serum albumin improves recovery from spinal cord injury

    AU - Cain, Lisa D.

    AU - Nie, Linghui

    AU - Hughes, Michael G.

    AU - Johnson, Kathia

    AU - Echetebu, Clement

    AU - Xu, Guo Ying

    AU - Hulsebosch, Claire E.

    AU - McAdoo, David J.

    PY - 2007/5/15

    Y1 - 2007/5/15

    N2 - A neuroprotective factor is shown to be present in mammalian serum. This factor is identified by Western blotting to be serum albumin. The serum factor and albumin both protected cultured spinal cord neurons against the toxicity of glutamate. The inability of K252a, a blocker of the high affinity tyrosine kinase receptor for members of the nerve growth factor family, to block the neuroprotective effect of the serum factor established that the serum factor is not a member of the nerve growth factor family. Post-injury injection of albumin intravenously or into the site of injury immediately after injury both improved significantly locomotor function according to Basso-Beattie-Bresnahan assessment and spontaneous locomotor activity recorded with a photobeam activity system. Albumin has multiple mechanisms whereby it may be neuroprotective, and it is a potentially useful agent for treating neurotraumas.

    AB - A neuroprotective factor is shown to be present in mammalian serum. This factor is identified by Western blotting to be serum albumin. The serum factor and albumin both protected cultured spinal cord neurons against the toxicity of glutamate. The inability of K252a, a blocker of the high affinity tyrosine kinase receptor for members of the nerve growth factor family, to block the neuroprotective effect of the serum factor established that the serum factor is not a member of the nerve growth factor family. Post-injury injection of albumin intravenously or into the site of injury immediately after injury both improved significantly locomotor function according to Basso-Beattie-Bresnahan assessment and spontaneous locomotor activity recorded with a photobeam activity system. Albumin has multiple mechanisms whereby it may be neuroprotective, and it is a potentially useful agent for treating neurotraumas.

    KW - Albumin

    KW - Neuroprotection

    KW - Spinal cord injury

    UR - http://www.scopus.com/inward/record.url?scp=34248232943&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=34248232943&partnerID=8YFLogxK

    U2 - 10.1002/jnr.21265

    DO - 10.1002/jnr.21265

    M3 - Article

    C2 - 17387687

    AN - SCOPUS:34248232943

    VL - 85

    SP - 1558

    EP - 1567

    JO - Journal of Neuroscience Research

    JF - Journal of Neuroscience Research

    SN - 0360-4012

    IS - 7

    ER -